Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial
P. Glue, C. Loo, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
P. R. Shiroma, P. Thuras, et al.
Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trial
R. D. Woodham, S. Selvaraj, et al.
Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression
J. Kopelman, T. A. Keller, et al.
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
M. I. Husain, D. M. Blumberger, et al.
